Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +3.66% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.17 | N/A | +3.66% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to long-term goals. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
While we did not provide guidance, we remain focused on our long-term strategy.
The earnings report indicates that Prestige Consumer HE managed to exceed EPS expectations, which contributed to a positive stock reaction, with shares rising 1.78%. The lack of revenue data and guidance leaves some uncertainty for investors, but the EPS beat suggests the company is on a solid path. Overall, the results reflect a cautious optimism from management about their performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VULCAN MATLS CO
Aug 3, 2009